Keyphrases
COVID-19
100%
Growth Arrest-specific Gene 6 (Gas6)
43%
Rheumatoid Arthritis
33%
Vitamin D
31%
Systemic Sclerosis
20%
SARS-CoV-2 Infection
20%
Bronchoalveolar Lavage
19%
Hospitalization
18%
Plasma Parameters
17%
Tyro3
17%
Connective Tissue Disease
16%
Pulmonary Arterial Hypertension
15%
Clinical Outcomes
15%
COVID-19 Patients
15%
Liver Stiffness
14%
Hospitalized Patients
14%
Type 2 Diabetes Mellitus (T2DM)
13%
Emergency Department
13%
Multiple Sclerosis
13%
Hospitalized COVID-19 Patients
13%
Comorbidity
13%
Moderate to Severe
13%
Plasma Concentration
12%
Fibrosis
12%
Italy
12%
Lung
12%
Chronic Liver Disease
12%
Sepsis
12%
Insulin Resistance
11%
Red Cell Distribution Width
11%
Hospital Discharge
11%
REPOSI
11%
Tocilizumab
11%
Osteopontin
11%
Non-alcoholic Fatty Liver Disease (NAFLD)
10%
Idiopathic Pulmonary Fibrosis
10%
Hepatitis C Virus
10%
Tyrosine Kinase Receptor
10%
Cerebrospinal Fluid
10%
Diabetes
10%
Odds Ratio
10%
Inflammation
10%
Mortality Prediction
9%
Depressive Symptoms
9%
HSD17B13
9%
Rituximab
9%
Italian Cohort
9%
Polymyalgia Rheumatica
9%
Calcitonin Gene-related Peptide
9%
Elderly Patients
9%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
48%
Coronavirinae
42%
Vitamin D
36%
SARS Coronavirus
29%
Biological Marker
28%
Infection
25%
Growth Disorder
23%
Diseases
17%
Rheumatoid Arthritis
16%
Inflammatory Arthritis
16%
Systemic Sclerosis
16%
Comorbidity
16%
Receptor
14%
Fibrosis
12%
Inflammation
11%
Liver Fibrosis
11%
Cholecalciferol
10%
Antivirus Agent
10%
Connective Tissue Disease
9%
Chronic Obstructive Lung Disease
9%
Disease Course
9%
Pulmonary Hypertension
9%
Prospective Cohort Study
9%
Hypovitaminosis D
8%
Diabetes Mellitus
8%
Hepatitis C Virus
8%
Cohort Study
8%
Lung Injury
8%
Insulin Resistance
7%
Non Insulin Dependent Diabetes Mellitus
7%
Cytokine
7%
Interferon
7%
Fibrosing Alveolitis
7%
Hepatitis C
7%
Rheumatic Disease
6%
Clinical Feature
6%
Nonalcoholic Fatty Liver
6%
Model Selection
6%
Adverse Outcome
6%
Hospital Mortality
6%
Lower Respiratory Tract Infection
6%
Depression
6%
Observational Study
6%
Prevalence
6%
Interstitial Lung Disease
5%
Malignant Neoplasm
5%
Dipeptidyl Carboxypeptidase Inhibitor
5%
Disease Modifying Antirheumatic Drug
5%
Rituximab
5%
Carbon Monoxide
5%
Medicine and Dentistry
COVID-19
65%
Biological Marker
31%
Infection
28%
Sequela
27%
Disease
25%
Severe Acute Respiratory Syndrome Coronavirus 2
24%
Fibrosis
19%
Growth Disorder
17%
Rheumatoid Arthritis
17%
Inflammatory Arthritis
17%
Lung Lavage
16%
Emergency Department
14%
Chronic Liver Disease
11%
Liver Fibrosis
11%
Lung
10%
Tocilizumab
10%
Idiopathic Pulmonary Fibrosis
10%
Systemic Scleroderma
10%
Liver Cirrhosis
10%
Postcovid Syndrome
9%
Pulmonary Hypertension
9%
Prospective Cohort Study
9%
Receptor
9%
Computer Assisted Tomography
9%
Connective Tissue Disease
8%
Rituximab
8%
Nasopharyngeal Swab
8%
DLCO
8%
Hepatitis C Virus
8%
Coronavirinae
8%
Chronic Hepatitis C
8%
Vitamin D
7%
Prevalence
7%
Comorbidity
7%
Cohort Analysis
7%
Hepatocellular Carcinoma
7%
Internal Medicine
7%
Transient Elastography
7%
Systematic Review
7%
Cardiovascular System
7%
Fatty Liver
7%
Growth Arrest Specific Protein 6
7%
Interstitial Lung Disease
6%
Rheumatic Disease
6%
Odds Ratio
6%
Adverse Outcome
6%
Congestive Heart Failure
6%
Hepatitis C
6%
Disease Course
6%
Allele
6%
